This inventor holds 1 USPTO granted patent. Top assignees: Stoecker & Associates, a Subsidiary of the Dermatology Center, LLC, University of Missouri. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2010
Title: The Innovations of Bijaya Shrestha
Introduction
Bijaya Shrestha is an accomplished inventor based in Rolla, MO (US). He has made significant contributions to the field of dermatology through his innovative patent. His work focuses on improving the diagnosis of malignant melanoma, which is crucial for early detection and treatment.
Latest Patents
Bijaya Shrestha holds a patent for "Automatic detection of critical dermoscopy features for malignant melanoma diagnosis." This patent presents improved methods for computer-aided analysis of identifying features of skin lesions from digital images. The innovations include enhanced preprocessing techniques that eliminate artifacts obscuring skin lesion features and identify pixel groups that represent or quantify these features. Additionally, the patent introduces improved digital hair removal algorithms and methods for analyzing lesion features.
Career Highlights
Throughout his career, Bijaya Shrestha has worked with notable organizations, including Stoecker & Associates, a subsidiary of the Dermatology Center, LLC, and the University of Missouri. His experience in these institutions has allowed him to develop and refine his innovative approaches to dermatological diagnostics.
Collaborations
Some of his notable coworkers include William V. Stoecker and Randy H. Moss. Their collaboration has contributed to the advancement of research and development in the field of dermatology.
Conclusion
Bijaya Shrestha's contributions to the field of dermatology through his innovative patent demonstrate his commitment to improving medical diagnostics. His work has the potential to significantly impact the early detection of malignant melanoma, ultimately benefiting patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile